3651 - 3660 of 4301 Drugs
Ondansetron Hydrochloride (Zofran) (ondansetron hydrochloride tablets)
Ondansetron Hydrochloride Tablets are a selective 5-HT3 receptor antagonist indicated for prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin =50 mg/m2; prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy; prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen; and prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively, ondansetron hydrochloride tablets are recommended even where the incidence of postoperative nausea and/or vomiting is low. Ondansetron is available in generic form. Common side effects of ondansetron include:
Zofran Injection (ondansetron hydrochloride injection)
Zofran (ondansetron hydrochloridc) Injection is an antiemetic (anti nausea and vomiting) used to prevent nausea and vomiting that may be caused by surgery or by medicine to treat cancer (chemotherapy). Zofran Injection is available in generic form.
Zofran (ondansetron hydrochloride tablets and solution)
Zofran (ondansetron) is an antiemetic and selective 5-HT3 receptor antagonist prescribed for the treatment of nausea and vomiting due to cancer chemotherapy and also used to prevent and treat nausea and vomiting after surgery. Zofran is available in generic form.
Zuplenz (ondansetron oral soluble film)
Zuplenz (ondansetron) Oral Soluble Film is an antiemetic used to prevent nausea and vomiting associated with cancer chemotherapy, radiotherapy, and surgery.
Ongentys (opicapone capsules)
Ongentys (opicapone) is a catechol-O-methyltransferase (COMT) inhibitor used as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes.
Onglyza (saxagliptin tablets)
Onglyza (saxagliptin) is an orally-active inhibitor of the DPP4 enzyme used either alone or with other medications, and with a proper diet and exercise program, to control high blood sugar. Onglyza is used in people with type 2 (non-insulin-dependent) diabetes.
Onpattro (patisiran lipid complex injection)
Onpattro (patisiran) contains a transthyretin-directed small interfering RNA and is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
Ontruzant (trastuzumab-dttb for injection)
Ontruzant (trastuzumab-dttb) is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer and for the treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Onzetra Xsail (sumatriptan nasal powder nasal administration)
Onzetra Xsail (sumatriptan nasal powder) is a serotonin 5-HT1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults.
Opana (oxymorphone hydrochloride)
Opana (oxymorphone hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain. The extended-release form of Opana is for around-the-clock treatment of pain. Opana is available in generic form.